NCT02730182 is a NA clinical trial of altitude exposure in Effect of High Altitude, sponsored by University of Zurich.

Who is sponsoring NCT02730182?

NCT02730182 is sponsored by University of Zurich.

What drugs are being tested in NCT02730182?

Interventions in NCT02730182: altitude exposure.

What condition does NCT02730182 study?

NCT02730182 studies Effect of High Altitude.

Is NCT02730182 still recruiting?

NCT02730182 is currently completed. Last updated 17 January 2019.

Last reviewed 2019-01-17 · How we verify

NCT02730182

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in Lowlanders

Completed NA Last updated 17 January 2019

What this trial tests

NA trial testing altitude exposure in Effect of High Altitude in 21 participants. Completed in 4 May 2016.

Timeline

9 April 2016

Primary endpoint
4 May 2016

4 May 2016

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	21
Start date	9 April 2016
Primary completion	4 May 2016
Estimated completion	4 May 2016
Sites	1 location across Switzerland

Drugs / interventions tested

altitude exposure

Conditions studied

Effect of High Altitude — all drugs for Effect of High Altitude →

Sponsor

University of Zurich

Who can join

Adults 18 to 65, any sex, with Effect of High Altitude. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure to high altitude on postural control

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of altitude exposure

Trials testing the same drug.

NCT02829255 — Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders · NA · completed
NCT02731456 — Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance in Lowlanders · NA · completed

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02730182 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 17 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02730182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing